150 related articles for article (PubMed ID: 35675485)
1. Favorable effect of rivaroxaban against vascular dysfunction in diabetic mice by inhibiting NLRP3 inflammasome activation.
Li Q; Yang XT; Wei W; Hu XP; Li XX; Xu M
J Cell Physiol; 2022 Aug; 237(8):3369-3380. PubMed ID: 35675485
[TBL] [Abstract][Full Text] [Related]
2. Empagliflozin ameliorates vascular calcification in diabetic mice through inhibiting Bhlhe40-dependent NLRP3 inflammasome activation.
Li XX; Chen ZD; Sun XJ; Yang YQ; Jin H; Liu NF
Acta Pharmacol Sin; 2024 Apr; 45(4):751-764. PubMed ID: 38172306
[TBL] [Abstract][Full Text] [Related]
3. [Protective effect of ginsenoside Rg_1 aganist diabetic retinopathy by inhibiting NLRP3 inflammasome in type 2 diabetic mice].
Li B; Zhang DC; Li XW; Dong XN; Li WP; Li WZ
Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(2):476-483. PubMed ID: 35178992
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of acarbose against vascular endothelial dysfunction through inhibiting Nox4/NLRP3 inflammasome pathway in diabetic rats.
Li XX; Ling SK; Hu MY; Ma Y; Li Y; Huang PL
Free Radic Biol Med; 2019 Dec; 145():175-186. PubMed ID: 31541678
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
Song W; Wei L; Du Y; Wang Y; Jiang S
Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
[TBL] [Abstract][Full Text] [Related]
6. NLRP3 inflammasome links vascular senescence to diabetic vascular lesions.
Tai GJ; Yu QQ; Li JP; Wei W; Ji XM; Zheng RF; Li XX; Wei L; Xu M
Pharmacol Res; 2022 Apr; 178():106143. PubMed ID: 35219871
[TBL] [Abstract][Full Text] [Related]
7. NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.
Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Jabir MS; Saad HM; Batiha GE
J Cell Mol Med; 2023 Jul; 27(13):1775-1789. PubMed ID: 37210624
[TBL] [Abstract][Full Text] [Related]
8. Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction.
Chen Y; Wang L; Pitzer AL; Li X; Li PL; Zhang Y
J Mol Med (Berl); 2016 Dec; 94(12):1335-1347. PubMed ID: 27783111
[TBL] [Abstract][Full Text] [Related]
9. Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis.
Yang SM; Ka SM; Wu HL; Yeh YC; Kuo CH; Hua KF; Shi GY; Hung YJ; Hsiao FC; Yang SS; Shieh YS; Lin SH; Wei CW; Lee JS; Yang CY; Chen A
Diabetologia; 2014 Feb; 57(2):424-34. PubMed ID: 24317792
[TBL] [Abstract][Full Text] [Related]
10. Ras guanine nucleotide-releasing protein-4 promotes renal inflammatory injury in type 2 diabetes mellitus.
Huang S; Wang J; Zhang L; Tian S; Wang Y; Shao X; Zhou S; Yu P
Metabolism; 2022 Jun; 131():155177. PubMed ID: 35218794
[TBL] [Abstract][Full Text] [Related]
11. NLRP3 Inflammasome and Mineralocorticoid Receptors Are Associated with Vascular Dysfunction in Type 2 Diabetes Mellitus.
Ferreira NS; Bruder-Nascimento T; Pereira CA; Zanotto CZ; Prado DS; Silva JF; Rassi DM; Foss-Freitas MC; Alves-Filho JC; Carlos D; Tostes RC
Cells; 2019 Dec; 8(12):. PubMed ID: 31817997
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes.
Gora IM; Ciechanowska A; Ladyzynski P
Cells; 2021 Feb; 10(2):. PubMed ID: 33546399
[TBL] [Abstract][Full Text] [Related]
14. A novel mechanism of diabetic vascular endothelial dysfunction: Hypoadiponectinemia-induced NLRP3 inflammasome activation.
Zhang J; Xia L; Zhang F; Zhu D; Xin C; Wang H; Zhang F; Guo X; Lee Y; Zhang L; Wang S; Guo X; Huang C; Gao F; Liu Y; Tao L
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1556-1567. PubMed ID: 28216285
[TBL] [Abstract][Full Text] [Related]
15. Melatonin ameliorates hepatic steatosis by inhibiting NLRP3 inflammasome in db/db mice.
Yu Y; Chen D; Zhao Y; Zhu J; Dong X
Int J Immunopathol Pharmacol; 2021; 35():20587384211036819. PubMed ID: 34399601
[TBL] [Abstract][Full Text] [Related]
16. Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction.
Boini KM; Hussain T; Li PL; Koka S
Cell Physiol Biochem; 2017; 44(1):152-162. PubMed ID: 29130962
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 gene knockout blocks NF-κB and MAPK signaling pathway in CUMS-induced depression mouse model.
Su WJ; Zhang Y; Chen Y; Gong H; Lian YJ; Peng W; Liu YZ; Wang YX; You ZL; Feng SJ; Zong Y; Lu GC; Jiang CL
Behav Brain Res; 2017 Mar; 322(Pt A):1-8. PubMed ID: 28093255
[TBL] [Abstract][Full Text] [Related]
18. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
Birnbaum Y; Bajaj M; Yang HC; Ye Y
Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
[TBL] [Abstract][Full Text] [Related]
19. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Xia Y; Zhang C; Zhang M; Zhang Y; An F
PLoS One; 2014; 9(8):e104771. PubMed ID: 25136835
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus.
Wang Y; Yu B; Wang L; Yang M; Xia Z; Wei W; Zhang F; Yuan X
PLoS One; 2017; 12(7):e0181248. PubMed ID: 28708885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
